NCT01857115View on ClinicalTrials.gov

Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

September 1, 2024

Conditions

Multiple Myeloma

Interventions

DRUG

Carfilzomib

DRUG

Cyclophosphamide

DRUG

Dexamethasone

Trial Locations (1)

10126

Fondazione EMN Italy Onlus, Torino

All Listed Sponsors

collaborator

Fondazione EMN Italy Onlus

OTHER

lead

European Myeloma Network B.V.

NETWORK

NCT01857115 - Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd) | Biotech Hunter | Biotech Hunter